Abstract
Background Autoimmune diseases and bone density loss (osteopenia and osteoporosis) are chronic conditions of complex aetiology that affect diverse populations. Folate may be associated with a higher risk of these disorders due to its essential role in one-carbon metabolism required for nucleotide synthesis, homocysteine metabolism, and methylation processes. However, the evidence on this association is inconclusive. Methods We searched MEDLINE, Embase, CINAHL, the Cochrane Library, and the Database of Abstracts of Reviews of Effects from inception to February 2024 for systematic reviews and meta-analyses investigating the associations between folate exposure (dietary intake, supplementation, or blood concentrations) and any autoimmune diseases or skeletal outcomes. Pairs of researchers screened the retrieved syntheses, extracted the relevant data, assessed their risk of bias using the ROBIS tool, and evaluated the credibility of the evidence using predefined criteria. Results We found 19 reviews reporting 25 unique associations: 15 on autoimmune diseases (multiple sclerosis, inflammatory bowel disease, psoriasis, human immunodeficiency virus, vitiligo, and systemic lupus erythematosus) and 10 on skeletal outcomes (fractures and bone mineral density loss). Most of the syntheses consisted of small-scale case-control studies. The risk of bias in the included syntheses was high. Owing to the small sample sizes, all the unique associations were assessed to be at a weak level of credibility. Conclusions The evidence on the relationship between folate status and autoimmune diseases or skeletal outcomes was limited in breadth and depth. Most of the 25 unique associations were reported by a single synthesis comprising small-scale studies. Subgroup analyses or dose-response analyses were severely limited or unavailable. More well-powered, prospective studies investigating the relationships between folate and autoimmune and skeletal conditions are warranted.
| Original language | English |
|---|---|
| Article number | 04257 |
| Pages (from-to) | 1-12 |
| Number of pages | 12 |
| Journal | Journal of Global Health |
| Volume | 16 |
| Early online date | 3 Jul 2026 |
| DOIs | |
| Publication status | Published online - 3 Jul 2026 |
Bibliographical note
Publisher Copyright:© 2026 The Author(s)
Data Availability Statement
The data supporting the findings of this study are available within the article and its supplementary materials.Funding
This study was funded by Canadian Institutes for Health Research (CIHR) Grant FRN-PJT-175263. The funder had no direct or indirect involvement in the design of the review, data abstraction, synthesis, writing of the report and decision to submit the manuscript for publication.
| Funders | Funder number |
|---|---|
| Public Health Agency of Canada | |
| Canadian Institutes of Health Research | FRN-PJT-175263 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Osteoporosis
- Bone Density
- Folic Acid/administration & dosage
- Global Health
- Humans
- Dietary Supplements
- Autoimmune Diseases/epidemiology
Fingerprint
Dive into the research topics of 'Folate and global health review series, part 4: syntheses on folate and autoimmune diseases and skeletal outcomes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver